Pfizer, Moderna, AstraZeneca.
Three weeks and three potential vaccines with extremely promising Phase III trial results that likely mean the first vaccinations will start within a few weeks.
These are remarkable scientific achievements well worth reading more about, but I want to focus on what this means for financial markets.
After stumbling through the darkness of much of this year, market participants finally see the light at the end of the Covid-19 tunnel. With a vaccine almost certainly coming within the next six months, and even sooner for targeted at-risk groups like doctors, nurses and other frontline workers, as well as the elderly, we can now plan ahead for a return to normalcy by next summer.